OVA raised over $1 million in a pre-seed funding round. Investment from top consumer VC and notable angels will fuel OVA's retail strategy with Boots and Sainsbury’s.WHO: Founded by former Net-a-Porter alums Danielle Fox-Thomas and Kat Lestage, OVA was born out of their lived experience with recurrent miscarriage and IVF and a frustration with the outdated fertility and prenatal vitamin offering. The duo is on a mission to reshape the fertility conversation—blending science, transparency, and cultural fluency to meet a new generation of fertility consumers where they are already shopping. WHY: This funding will power OVA’s next chapter of growth, including expansion into Ireland, scaling retail distribution, and strengthening its partnership across 800+ retail locations in Boots and Sainsbury's, and supporting their collaboration with Google through their high-growth new business program.IN THEIR OWN WORDS: “We built OVA because the fertility aisle hasn’t caught up with the reality of how people are actually trying to conceive,” said Kat Lestage, co-founder. “People deserve better than cold medicinal packaging and vague promises—they deserve products that are evidence-based, gender-inclusive, and rooted in empathy.”“Just after seven months of launching, this raise is a huge vote of confidence in the future we’re building,” added Danielle Fox-Thomas, co-founder. “We’re here to make fertility support smarter, more accessible, and less isolating—and we’re just getting started.”Claire Cherry, Partner at ERA VC, said, “OVA is tapping into a deeply underserved space in a truly differentiated manner.